Presentation is loading. Please wait.

Presentation is loading. Please wait.

Lecturer: Gorishna Ivanna Lubomyrivna

Similar presentations


Presentation on theme: "Lecturer: Gorishna Ivanna Lubomyrivna"— Presentation transcript:

1 Lecturer: Gorishna Ivanna Lubomyrivna
Functional and organic diseases of liver and bile ducts. Etiology, pathogenesis, clinical features, diagnostics, treatment and prophylactic Lecturer: Gorishna Ivanna Lubomyrivna

2 Plan of the lecture Definition of biliary dyskinesia
Biliary dyskinesia classification Clinical manifestation Methods of examinations Treatment of the different kinds of biliary dyskinesia Definition of the chronic hepatitis Hepatitis classification Treatment of the different kinds of hepatitis

3 Definition of the Biliary Dyskinesia
is a disorder of the sphincter’ tonus and kinetics of the gall-bladder and bile ducts.

4 Classification hypertonic-hyperkinetic dyskinesia
hypotonic-hypokinetic dyskinesia

5 Clinical manifestation of hypertonic-hyperkinetic dyskinesia
Duration of the disease up to 1 yr. Pain syndrome Dyspeptic syndrome Manifestations of vegetative dysfunction, neurotic symptoms

6 Clinical manifestation of hypotonic-hypokinetic dyskinesia
Pain syndrome Dyspeptic syndrome Hepatomegaly Gallbladder symptoms are positive

7 Plan of examination Fool blood count Biochemical test of blood
Serum aminotransferase Serum bilirubin (predominantly the direct reacting fraction) Serum alkaline phosphatase Albumin and globulin level Stool test USE of the abdominal cavity + cholekynetics for functional investigations

8 Stool test: Norma Biliary dyskinesia
indigested muscular fibers non-digestable cellulose digestable cellulose fatty acids mucous epithelium leucocytes erythrocytes 1-2-3 + + 0-1 ++++

9

10 Duodenal intubation

11 Duodenal intubation A I 10-20 Golden-yellow 0.2-1.4 8-22 II 2-6 - III
Portion phase Duration (min) Color Speed of bile excretion Total volume, ml A I 10-20 Golden-yellow 8-22 II 2-6 - III 3-5 yellow

12 Duodenal intubation B IV 20-30 Brown 1.1-2.5 15-30 C V Golden-yellow
Portion phase Duration (min) Color Speed of bile excretion Total volume, ml B IV 20-30 Brown 15-30 C V Golden-yellow Constant

13 Duodenal intubation A Golden yellow ↑ 7 5-10 - -+ B Brown C
Portion Colour pH Epithelium Leucocyte Lamblia Mu-cus A Golden yellow ↑ 7 5-10 - -+ B Brown C Bright yellow

14 Duodenal intubation A Yellow-green 6.2 5-6 - B Brown-green 5.5 3-5 3-6
Portion Color pH Epithelium Leucocytes Lamblia Mu-cus A Yellow-green 6.2 5-6 - B Brown-green 5.5 3-5 3-6 C yellow 7.2 4-6 2-4

15 USE of the abdominal cavity + cholekinetics for functional investigations
cholekinetics lead to a contraction of the gallbladder for 1/2-2/3 of the previous volume hypertonic dyskinesia - contraction of the gallbladder more than 2/3 of the previous volume hypotonic dyskinesia - contraction of the gallbladder less than 1/2 of the previous volume

16 Diet 5 Exclude heavy fats (like pork), spices, fried foods, "fast food"”; avoid stimulators of gastrointestinal secretions, the diet must be rich by metionine, lecithin, and choline to stimulate synthesis of proteins and enzymes in the liver. Diet with normal value of proteins and vitamins, with restriction of fats and carbohydrates is administered, also restrict salt. Foods boiled, steamed and baked are recommended; food taking 5 times daily

17 Treatment of hypertonic-hyperkinetic dyskinesia
Diet N 5 Spasmolitics: platyphyllini hydrotartratis (amp. 0.2 % 1 ml) papaverini hydrochloridum (tab. 0.01, amp. 2 % 2 ml) no-spa (tab or amp. 2 % 2 ml) Choleretic: cholagon allocholum cholenzynum galstena hepabene

18 Blind Duodenal intubation
with magnesii sulfatis 33 % xylitol or sorbitol 10 %

19 Chronic cholecystitis and cholecystocholangitis
Chronic recurrent inflammatory process of gallbladder and intrahepatic bile ducts, accompanied with bile ducts motor disorders

20 Clinical manifestation
Pain syndrome Dyspeptic syndrome Intoxication syndrome Cholestasis Inflammatory syndrome Dyscholia Ph of bile is acidic USE

21 Duodenal intubation Portion Color pH Epithelium Leucocytes Lamblia
mucus A green 6.2 8-10 6-8 + B Brown-green 4.5 40-50 55-60 - C yellow 7.2 10-16 9-16

22 Definition of the chronic hepatitis
a continuing hepatic inflammatory process manifested by elevated hepatic transaminase level, lasting 6 mo or more and accompanied with pain, dyspeptic, intoxication and cholestatic syndromes

23

24 Classification of the hepatitis
Forms of chronic hepatitis: 1. Chronic viral hepatitis (В, С, D) 2. Autoimmune hepatitis 3. Drug-induced hepatitis 4. Toxic hepatitis 5. Cryptogenic

25 The activity of the chronic hepatitis
Active period: а) mild activity (elevation of ALT < 3 times); б) moderate activity (elevation of ALT < 10 times); в) severe activity (elevation of ALT >10 times). Inactive period

26 Stages of chronic hepatitis
0- fibrosis is absent; 1- mild fibrosis; 2- moderate fibrosis; 3- severe fibrosis; 4- cirrhosis.

27

28

29

30

31 Clinical manifestation
Pain syndrome Dyspeptic syndrome Intoxication syndrome

32 Objective examination shows
Inadequate weight gain or failure to thrive Sexual delay Jaundice Pruritus Hyperpigmentation or hypopigmentation of the skin Symptoms of hypovitaminosis Telangiectasias (spider angiomas) Palmar erythema Clubbing fingers

33 Jaundice

34 Jaundice

35 Objective examination shows
Hepatic smell Hepatomegaly Symptoms of portal hypertension Splenomegaly Ascites Collateral circulation Splenism Hemorrhagic syndrome Encephalopathy

36 Hepato-spleno-megaly

37 Collateral circulation in case of biliary cirrhosis

38 Plan examination Fool blood count Biochemical test of blood Stool test
Serum aminotransferare Serum bilirubin (predominantly the direct reacting fraction) Serum alkaline phosphatase Serum γ-globulin levels Albumin and globulin level The prothrombin time serum iron and serum ferritin Stool test USE of the abdominal cavity

39

40 Tests in case viral hepatitis
ELISA test PCR examination Quantitative PCR Viral genotyping

41 HBV serum markers HBsAg HBsAb (recovering) HBeAg HBeAb HBcAb Ig M
HBc Ab Ig G (recovering) HBV DNA

42 Modern treatment of viral hepatitis
HBV: Interferon+Lamivudine. the doses of Lamivudine is 3 mg/kg (up to 100 mg) once per day HСV: Interferon+Ribavirin the doses of Ribavirin is mg once per day


Download ppt "Lecturer: Gorishna Ivanna Lubomyrivna"

Similar presentations


Ads by Google